Fresenius Adds To Denosumab Competitors In Europe

As Neuraxpharm Gets EMA Nod For Tecfidera Hybrid

 
• By Dave Wallace
  
European Medicines Agency Sign Amsterdam
The EMA’s CHMP has endorsed further denosumab biosimilars • Source: Alamy

More from Biosimilars

More from Policy & Regulation